Related Experiment Video
Updated: Aug 11, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Fibrinolysis at the fluid-solid interface of thrombi
K Kolev1, C Longstaff, R Machovich
1Department of Medical Biochemistry, Semmelweis University, Puskin u. 9., H-1088 Budapest, Hungary. kale@puskin.sote.hu
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|October 28, 2005
Summary
Thrombolysis, the breakdown of blood clots, is better understood through new interfacial methods. These reveal how clot composition limits current therapies by hindering plasminogen activation and fibrinolysis.
Area of Science:
- Biochemistry
- Molecular Biology
- Medical Science
Background:
- Thrombolysis conventionally dissolves fibrin clots via plasmin, generated from plasminogen.
- Plasminogen activation and plasmin's action primarily occur at the fluid-solid interface of thrombi.
- Classical enzymology inadequately explains interfacial fibrinolytic events.
Purpose of the Study:
- To present new methodologies for quantitatively evaluating interfacial plasminogen activation and proteolysis.
- To elucidate the mechanisms limiting current thrombolytic therapy.
- To propose a model of thrombi as temporary fibrinolytic compartments.
Main Methods:
- Quantitative evaluation of plasminogen activation on gel-phase fibrin.
- Analysis of heterogeneous-phase proteolysis.
- Investigating diffusion and permeation phenomena within thrombi.
- Examining the role of phospholipids and cellular proteins (myosin) in thrombolysis.
- Studying the impact of proteinase inhibitors on fibrinolysis.
Main Results:
- New methods allow quantitative assessment of interfacial plasminogen activation and proteolysis.
- Clot composition, including phospholipids and myosin, creates barriers and masks sites, limiting thrombolysis.
- Interfacial events influence the initiation, progression, and termination of fibrinolysis within thrombi.
Conclusions:
- Understanding interfacial fibrinolysis is crucial for improving thrombolytic therapy.
- Thrombi can be modeled as temporary fibrinolytic compartments based on interfacial events.
- New insights into clot structure and inhibition mechanisms offer avenues for enhanced therapeutic strategies.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...